B. Riley Weighs in on Mirion Technologies, Inc.’s Q3 2024 Earnings (NYSE:MIR)

Mirion Technologies, Inc. (NYSE:MIR) – B. Riley issued their Q3 2024 earnings per share (EPS) estimates for Mirion Technologies in a report issued on Wednesday, September 25th. B. Riley analyst Y. Zhi expects that the company will post earnings of $0.11 per share for the quarter. B. Riley currently has a “Strong-Buy” rating on the stock. B. Riley also issued estimates for Mirion Technologies’ Q4 2024 earnings at $0.10 EPS and FY2024 earnings at $0.37 EPS.

Mirion Technologies Stock Down 1.2 %

MIR stock opened at $10.94 on Monday. The firm has a market cap of $2.49 billion, a price-to-earnings ratio of -26.68 and a beta of 0.79. Mirion Technologies has a 1-year low of $6.70 and a 1-year high of $11.78. The firm has a fifty day moving average price of $10.41 and a two-hundred day moving average price of $10.61. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.18 and a quick ratio of 1.55.

Mirion Technologies (NYSE:MIR) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.03. The business had revenue of $207.10 million during the quarter, compared to the consensus estimate of $210.77 million. Mirion Technologies had a positive return on equity of 3.81% and a negative net margin of 7.80%. The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period last year, the firm earned $0.08 earnings per share.

Hedge Funds Weigh In On Mirion Technologies

Hedge funds have recently made changes to their positions in the business. Innealta Capital LLC purchased a new position in Mirion Technologies during the 2nd quarter worth approximately $39,000. Central Pacific Bank Trust Division bought a new position in Mirion Technologies during the first quarter worth $85,000. Algert Global LLC acquired a new position in shares of Mirion Technologies during the second quarter valued at about $189,000. Bayesian Capital Management LP acquired a new position in Mirion Technologies in the 1st quarter valued at approximately $226,000. Finally, Lazard Asset Management LLC raised its stake in shares of Mirion Technologies by 19.8% in the first quarter. Lazard Asset Management LLC now owns 22,751 shares of the company’s stock valued at $258,000 after purchasing an additional 3,753 shares in the last quarter. Institutional investors and hedge funds own 78.51% of the company’s stock.

Insider Buying and Selling at Mirion Technologies

In related news, insider Loic Eloy sold 22,139 shares of the stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $9.91, for a total value of $219,397.49. Following the sale, the insider now owns 177,663 shares of the company’s stock, valued at approximately $1,760,640.33. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, insider Loic Eloy sold 22,139 shares of Mirion Technologies stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $9.91, for a total transaction of $219,397.49. Following the sale, the insider now directly owns 177,663 shares in the company, valued at $1,760,640.33. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Thomas D. Logan sold 7,500 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $11.00, for a total transaction of $82,500.00. Following the completion of the sale, the chief executive officer now directly owns 1,544,017 shares of the company’s stock, valued at $16,984,187. The disclosure for this sale can be found here. Insiders sold a total of 54,639 shares of company stock worth $568,947 over the last ninety days. Company insiders own 2.20% of the company’s stock.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.